Company Elite Pharmaceuticals Inc OTC Bulletin Board
Equities
US28659T2006
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Jul. 02 | Transcript : Elite Pharmaceuticals, Inc., Q4 2024 Earnings Call, Jul 02, 2024 | |
Jul. 01 | Elite Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Business Summary
Sales per Business
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Abbreviated New Drug Applications
100.0
%
| 34 | 100.0 % | 57 | 100.0 % | +65.79% |
Sales per region
USD in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 34 | 100.0 % | 57 | 100.0 % | +65.79% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Christopher Dick
CEO | Chief Executive Officer | 69 | 02-10-31 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 09-06-30 |
Douglas Plassche
COO | Chief Operating Officer | 61 | 13-08-11 |
Dianne Will
IRC | Investor Relations Contact | - | 02-12-31 |
Kirko Kirkov
PRN | Corporate Officer/Principal | 56 | 22-09-05 |
George Smith
LAW | General Counsel | - | 14-10-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 09-10-22 |
Barry Dash
BRD | Director/Board Member | 93 | 05-03-31 |
Davis Caskey
BRD | Director/Board Member | 76 | 16-04-27 |
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,068,373,108 | 781,612,414 ( 73.16 %) | 100,000 ( 0.009360 %) | 73.16 % |
Company contact information
![address Elite Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/5333258.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+25.24% | 45.32B | |
+34.85% | 24.51B | |
+29.56% | 16.85B | |
+21.32% | 14.62B | |
+70.51% | 14.16B | |
-0.05% | 6.79B | |
+15.74% | 5.82B | |
-8.87% | 5.73B | |
+10.29% | 4.93B |
- Stock Market
- Equities
- ELTP Stock
- Stock
- Company Elite Pharmaceuticals Inc